| Making sense of G‐quadruplex and i‐motif functions in oncogene promoters TA Brooks, S Kendrick, L Hurley The FEBS journal 277 (17), 3459-3469, 2010 | 559 | 2010 |
| The Dynamic Character of the BCL2 Promoter i-Motif Provides a Mechanism for Modulation of Gene Expression by Compounds That Bind Selectively to the … S Kendrick, HJ Kang, MP Alam, MM Madathil, P Agrawal, V Gokhale, ... Journal of the American Chemical Society 136 (11), 4161-4171, 2014 | 296 | 2014 |
| The Transcriptional Complex Between the BCL2 i-Motif and hnRNP LL Is a Molecular Switch for Control of Gene Expression That Can Be Modulated by Small … HJ Kang, S Kendrick, SM Hecht, LH Hurley Journal of the American Chemical Society 136 (11), 4172-4185, 2014 | 262 | 2014 |
| The i-Motif in the bcl-2 P1 Promoter Forms an Unexpectedly Stable Structure with a Unique 8:5:7 Loop Folding Pattern S Kendrick, Y Akiyama, SM Hecht, LH Hurley Journal of the American Chemical Society 131 (48), 17667-17676, 2009 | 167 | 2009 |
| Synergistic induction of apoptosis in high-risk DLBCL by BCL2 inhibition with ABT-199 combined with pharmacologic loss of MCL1 L Li, P Pongtornpipat, T Tiutan, SL Kendrick, S Park, DO Persky, ... Leukemia 29 (8), 1702-1712, 2015 | 108 | 2015 |
| The role of G-quadruplex/i-motif secondary structures as cis-acting regulatory elements S Kendrick, LH Hurley Pure and Applied Chemistry 82 (8), 1609-1621, 2010 | 98 | 2010 |
| The i-motif as a molecular target: more than a complementary DNA secondary structure SL Brown, S Kendrick Pharmaceuticals 14 (2), 96, 2021 | 61 | 2021 |
| Inhibition by doxycycline of angiogenesis in the chicken chorioallantoic membrane (CAM) M Richardson, D Wong, S Lacroix, J Stanisz, G Singh Cancer chemotherapy and pharmacology 56, 1-9, 2005 | 41 | 2005 |
| Simultaneous Drug Targeting of the Promoter MYC G-Quadruplex and BCL2 i-Motif in Diffuse Large B-Cell Lymphoma Delays Tumor Growth S Kendrick, A Muranyi, V Gokhale, LH Hurley, LM Rimsza Journal of Medicinal Chemistry 60 (15), 6587-6597, 2017 | 38 | 2017 |
| BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma SL Kendrick, L Redd, A Muranyi, LA Henricksen, S Stanislaw, LM Smith, ... Human pathology 45 (10), 2144-2153, 2014 | 37 | 2014 |
| Colorimetric In Situ Hybridization Identifies MYC Gene Signal Clusters Correlating With Increased Copy Number, mRNA, and Protein in Diffuse Large B-Cell … C Valentino, S Kendrick, N Johnson, R Gascoyne, WC Chan, ... American journal of clinical pathology 139 (2), 242-254, 2013 | 35 | 2013 |
| Molecular classification, pathway addiction, and therapeutic targeting in diffuse large B cell lymphoma S Puvvada, S Kendrick, L Rimsza Cancer genetics 206 (7-8), 257-265, 2013 | 29 | 2013 |
| ProteoViz: a tool for the analysis and interactive visualization of phosphoproteomics data AJ Storey, KS Naceanceno, RS Lan, CL Washam, LM Orr, SG Mackintosh, ... Molecular omics 16 (4), 316-326, 2020 | 24 | 2020 |
| Clinical implications of loss of bone marrow minimal residual disease negativity in multiple myeloma M Mohan, S Kendrick, A Szabo, N Yarlagadda, D Atwal, Y Pandey, A Roy, ... Blood Advances 6 (3), 808-817, 2022 | 21 | 2022 |
| Enhanced DNA repair and genomic stability identify a novel HIV‐related diffuse large B‐cell lymphoma signature A Maguire, X Chen, L Wisner, S Malasi, C Ramsower, S Kendrick, ... International Journal of Cancer 145 (11), 3078-3088, 2019 | 20 | 2019 |
| The anti-COVID-19 drug remdesivir promotes oncogenic herpesvirus reactivation through regulation of intracellular signaling pathways J Chen, L Dai, S Kendrick, SR Post, Z Qin Antimicrobial agents and chemotherapy 66 (3), e02395-21, 2022 | 18 | 2022 |
| Activation-induced cytidine deaminase localizes to G-quadruplex motifs at mutation hotspots in lymphoma YZ Xu, P Jenjaroenpun, T Wongsurawat, SD Byrum, V Shponka, ... NAR cancer 2 (4), zcaa029, 2020 | 17 | 2020 |
| Intramolecular cyclization of imidazo [1, 2-a] pyridines via a silver mediated/palladium catalyzed C–H activation strategy D Saha, A Kharbanda, N Essien, L Zhang, R Cooper, D Basak, ... Organic Chemistry Frontiers 6 (13), 2234-2239, 2019 | 15 | 2019 |
| Diffuse large B-cell lymphoma cell-of-origin classification using the Lymph2Cx assay in the context of BCL2 and MYC expression status S Kendrick, K Tus, G Wright, ES Jaffe, A Rosenwald, E Campo, WC Chan, ... Leukemia & lymphoma 57 (3), 717-720, 2016 | 14 | 2016 |
| Identification of natural compounds tubercidin and lycorine HCl against small‐cell lung cancer and BCAT1 as a therapeutic target J Chen, L Barrett, Z Lin, S Kendrick, S Mu, L Dai, Z Qin Journal of Cellular and Molecular Medicine 26 (9), 2557-2565, 2022 | 9 | 2022 |
